Fibroblasts in cancer (original) (raw)

• Kalluri, R. Basement membranes: structure, assembly and role in tumour angiogenesis. Nature Rev. Cancer 3, 422–433 (2003). A comprehensive review on ECM and tumour angiogenesis.
  Article CAS Google Scholar
• Folkman, J. Tumor angiogenesis: therapeutic implications. N. Engl. J. Med. 285, 1182–1186 (1971). The first publication to indicate that angiogenesis is a target for controlling cancer.
  Article CAS PubMed Google Scholar
• O'Reilly, M. S. et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88, 277–285 (1997).
  Article CAS PubMed Google Scholar
• Ishii, G. et al. Bone-marrow-derived myofibroblasts contribute to the cancer-induced stromal reaction. Biochem. Biophys. Res. Commun. 309, 232–240 (2003).
  Article CAS PubMed Google Scholar
• Kim, K. J. et al. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 362, 841–844 (1993).
  Article CAS PubMed Google Scholar
• Coussens, L. M. & Werb, Z. Inflammation and cancer. Nature 420, 860–867 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• de Visser, K. E., Korets, L. V. & Coussens, L. M. De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent. Cancer Cell 7, 411–423 (2005).
  Article CAS PubMed Google Scholar
• Tlsty, T. D. & Hein, P. W. Know thy neighbor: stromal cells can contribute oncogenic signals. Curr. Opin. Genet. Dev. 11, 54–59 (2001). An interesting review of tumour stromal cells and their role in oncogenic manipulation.
  Article CAS PubMed Google Scholar
• Elenbaas, B. & Weinberg, R. A. Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation. Exp. Cell Res. 264, 169–184 (2001).
  Article CAS PubMed Google Scholar
• Mueller, M. M. & Fusenig, N. E. Friends or foes — bipolar effects of the tumour stroma in cancer. Nature Rev. Cancer 4, 839–849 (2004). An in-depth review about tumour stroma.
  Article CAS Google Scholar
• Virchow, R. Die Cellularpathologie in Ihrer Begruendung auf Physiologische und Pathologische Gewebelehre (Hirschwald, A., Berlin, Germany, 1858).
  Google Scholar
• Duvall, M. Atlas d'Embryologie (Masson, Paris, 1879).
  Google Scholar
• Tarin, D. & Croft, C. B. Ultrastructural features of wound healing in mouse skin. J. Anat. 105, 189–190 (1969).
  CAS PubMed Google Scholar
• Tomasek, J. J., Gabbiani, G., Hinz, B., Chaponnier, C. & Brown, R. A. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nature Rev. Mol. Cell Biol. 3, 349–363 (2002).
  Article CAS Google Scholar
• Parsonage, G. et al. A stromal address code defined by fibroblasts. Trends Immunol. 26, 150–156 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Rodemann, H. P. & Muller, G. A. Characterization of human renal fibroblasts in health and disease: II. In vitro growth, differentiation, and collagen synthesis of fibroblasts from kidneys with interstitial fibrosis. Am. J. Kidney Dis. 17, 684–686 (1991).
  Article CAS PubMed Google Scholar
• Chang, H. Y. et al. Diversity, topographic differentiation, and positional memory in human fibroblasts. Proc. Natl Acad. Sci. USA 99, 12877–12882 (2002). This study compares primary fibroblasts that were isolated from various sites and sheds new light on the vast diversity of fibroblasts.
  Article CAS PubMed PubMed Central Google Scholar
• Simian, M. et al. The interplay of matrix metalloproteinases, morphogens and growth factors is necessary for branching of mammary epithelial cells. Development 128, 3117–3131 (2001).
  Article CAS PubMed Google Scholar
• Wiseman, B. S. & Werb, Z. Stromal effects on mammary gland development and breast cancer. Science 296, 1046–1049 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Castor, C. W., Wilson, S. M., Heiss, P. R. & Seidman, J. C. Activation of lung connective tissue cells in vitro. Am. Rev. Respir. Dis. 120, 101–106 (1979).
  CAS PubMed Google Scholar
• Muller, G. A. & Rodemann, H. P. Characterization of human renal fibroblasts in health and disease: I. Immunophenotyping of cultured tubular epithelial cells and fibroblasts derived from kidneys with histologically proven interstitial fibrosis. Am. J. Kidney Dis. 17, 680–683. (1991).
  Article CAS PubMed Google Scholar
• Hanahan, D. & Weinberg, R. A. The hallmarks of cancer. Cell 100, 57–70 (2000). A comprehensive review on cancer.
  Article CAS PubMed Google Scholar
• Ronnov-Jessen, L., Petersen, O. W. & Bissell, M. J. Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. Physiol. Rev. 76, 69–125 (1996).
  Article CAS PubMed Google Scholar
• Dvorak, H. F., Form, D. M., Manseau, E. J. & Smith, B. D. Pathogenesis of desmoplasia. I. Immunofluorescence identification and localization of some structural proteins of line 1 and line 10 guinea pig tumors and of healing wounds. J. Natl Cancer Inst. 73, 1195–1205 (1984).
  CAS PubMed Google Scholar
• Dolberg, D. S., Hollingsworth, R., Hertle, M. & Bissell, M. J. Wounding and its role in RSV-mediated tumor formation. Science 230, 676–678 (1985).
  Article CAS PubMed Google Scholar
• Sieweke, M. H., Thompson, N. L., Sporn, M. B. & Bissell, M. J. Mediation of wound-related Rous sarcoma virus tumorigenesis by TGF-β. Science 248, 1656–1660 (1990).
  Article CAS PubMed Google Scholar
• Brown, L. F. et al. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast. Clin. Cancer Res. 5, 1041–1056 (1999).
  CAS PubMed Google Scholar
• Fukumura, D. et al. Tumor induction of VEGF promoter activity in stromal cells. Cell 94, 715–725 (1998).
  Article CAS PubMed Google Scholar
• Senger, D. R. et al. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219, 983–985 (1983).
  Article CAS PubMed Google Scholar
• Dvorak, H. F. et al. Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels. J. Exp. Med. 174, 1275–1278 (1991).
  Article CAS PubMed Google Scholar
• Feng, D. et al. Ultrastructural localization of the vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) receptor-2 (FLK-1, KDR) in normal mouse kidney and in the hyperpermeable vessels induced by VPF/VEGF-expressing tumors and adenoviral vectors. J. Histochem. Cytochem. 48, 545–556 (2000).
  Article CAS PubMed Google Scholar
• Leung, D. W., Cachianes, G., Kuang, W. J., Goeddel, D. V. & Ferrara, N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246, 1306–1309 (1989).
  Article CAS PubMed Google Scholar
• Dvorak, H. F. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N. Engl. J. Med. 315, 1650–1659 (1986).
  Article CAS PubMed Google Scholar
• Schedin, P. & Elias, A. Multistep tumorigenesis and the microenvironment. Breast Cancer Res. 6, 93–101 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Shekhar, M. P., Pauley, R. & Heppner, G. Host microenvironment in breast cancer development: extracellular matrix–stromal cell contribution to neoplastic phenotype of epithelial cells in the breast. Breast Cancer Res. 5, 130–135 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• van Kempen, L. C., Ruiter, D. J., van Muijen, G. N. & Coussens, L. M. The tumor microenvironment: a critical determinant of neoplastic evolution. Eur. J. Cell Biol. 82, 539–548 (2003).
  Article PubMed Google Scholar
• Brown, L. F., Dvorak, A. M. & Dvorak, H. F. Leaky vessels, fibrin deposition, and fibrosis: a sequence of events common to solid tumors and to many other types of disease. Am. Rev. Respir. Dis. 140, 1104–1107 (1989).
  Article CAS PubMed Google Scholar
• Folkman, J., Watson, K., Ingber, D. & Hanahan, D. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 339, 58–61 (1989).
  Article CAS PubMed Google Scholar
• Chiquet-Ehrismann, R., Mackie, E. J., Pearson, C. A. & Sakakura, T. Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis. Cell 47, 131–139 (1986).
  Article CAS PubMed Google Scholar
• Mackie, E. J. et al. Tenascin is a stromal marker for epithelial malignancy in the mammary gland. Proc. Natl Acad. Sci. USA 84, 4621–4625 (1987).
  Article CAS PubMed PubMed Central Google Scholar
• Ishihara, A., Yoshida, T., Tamaki, H. & Sakakura, T. Tenascin expression in cancer cells and stroma of human breast cancer and its prognostic significance. Clin. Cancer Res. 1, 1035–1041 (1995).
  CAS PubMed Google Scholar
• Brunner, A. et al. Prognostic significance of tenascin-C-expression in superficial and invasive bladder cancer. J. Clin. Pathol. 57, 927–931 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• De Wever, O. & Mareel, M. Role of myofibroblasts at the invasion front. Biol. Chem. 383, 55–67 (2002).
  Article CAS PubMed Google Scholar
• Bertrand, P. et al. Hyaluronan (hyaluronic acid) and hyaluronectin in the extracellular matrix of human breast carcinomas: comparison between invasive and non-invasive areas. Int. J. Cancer 52, 1–6 (1992).
  Article CAS PubMed Google Scholar
• Barsky, S. H. & Gopalakrishna, R. Increased invasion and spontaneous metastasis of BL6 melanoma with inhibition of the desmoplastic response in C57 BL/6 mice. Cancer Res. 47, 1663–1667 (1987).
  CAS PubMed Google Scholar
• Netti, P. A., Berk, D. A., Swartz, M. A., Grodzinsky, A. J. & Jain, R. K. Role of extracellular matrix assembly in interstitial transport in solid tumors. Cancer Res. 60, 2497–2503 (2000).
  CAS PubMed Google Scholar
• Brown, E. B., Boucher, Y., Nasser, S. & Jain, R. K. Measurement of macromolecular diffusion coefficients in human tumors. Microvasc. Res. 67, 231–236 (2004).
  Article CAS PubMed Google Scholar
• Hynes, R. O. Integrins: versatility, modulation, and signaling in cell adhesion. Cell 69, 11–25 (1992).
  Article CAS PubMed Google Scholar
• Ryan, G. B. et al. Myofibroblasts in an avascular fibrous tissue. Lab. Invest. 29, 197–206 (1973).
  CAS PubMed Google Scholar
• Ryan, G. B. et al. Myofibroblasts in human granulation tissue. Hum. Pathol. 5, 55–67 (1974).
  Article CAS PubMed Google Scholar
• Tsukada, T., McNutt, M. A., Ross, R. & Gown, A. M. HHF35, a muscle actin-specific monoclonal antibody. II. Reactivity in normal, reactive, and neoplastic human tissues. Am. J. Pathol. 127, 389–402 (1987).
  CAS PubMed PubMed Central Google Scholar
• Schor, S. L., Schor, A. M., Grey, A. M. & Rushton, G. Foetal and cancer patient fibroblasts produce an autocrine migration-stimulating factor not made by normal adult cells. J. Cell Sci. 90, 391–399 (1988).
  Article CAS PubMed Google Scholar
• Durning, P., Schor, S. L. & Sellwood, R. A. Fibroblasts from patients with breast cancer show abnormal migratory behaviour in vitro. Lancet 2, 890–892 (1984).
  Article CAS PubMed Google Scholar
• Barsky, S. H., Green, W. R., Grotendorst, G. R. & Liotta, L. A. Desmoplastic breast carcinoma as a source of human myofibroblasts. Am. J. Pathol. 115, 329–333 (1984).
  CAS PubMed PubMed Central Google Scholar
• Sappino, A. P., Skalli, O., Jackson, B., Schurch, W. & Gabbiani, G. Smooth-muscle differentiation in stromal cells of malignant and non-malignant breast tissues. Int. J. Cancer 41, 707–712 (1988).
  Article CAS PubMed Google Scholar
• Gabbiani, G. The myofibroblast in wound healing and fibrocontractive diseases. J. Pathol. 200, 500–503 (2003).
  Article CAS PubMed Google Scholar
• Ronnov-Jessen, L. & Petersen, O. W. Induction of α-smooth muscle actin by transforming growth factor-β1 in quiescent human breast gland fibroblasts. Implications for myofibroblast generation in breast neoplasia. Lab. Invest. 68, 696–707 (1993).
  CAS PubMed Google Scholar
• Lohr, M. et al. Transforming growth factor-β1 induces desmoplasia in an experimental model of human pancreatic carcinoma. Cancer Res. 61, 550–555 (2001).
  CAS PubMed Google Scholar
• Aoyagi, Y. et al. Overexpression of TGF-β by infiltrated granulocytes correlates with the expression of collagen mRNA in pancreatic cancer. Br. J. Cancer 91, 1316–1326 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Akhurst, R. J. TGF-β antagonists: why suppress a tumor suppressor? J. Clin. Invest. 109, 1533–1536 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Bronzert, D. A. et al. Synthesis and secretion of platelet-derived growth factor by human breast cancer cell lines. Proc. Natl Acad. Sci. USA 84, 5763–5767 (1987).
  Article CAS PubMed PubMed Central Google Scholar
• Forsberg, K., Valyi-Nagy, I., Heldin, C. H., Herlyn, M. & Westermark, B. Platelet-derived growth factor (PDGF) in oncogenesis: development of a vascular connective tissue stroma in xenotransplanted human melanoma producing PDGF-BB. Proc. Natl Acad. Sci. USA 90, 393–397 (1993).
  Article CAS PubMed PubMed Central Google Scholar
• Shao, Z. M., Nguyen, M. & Barsky, S. H. Human breast carcinoma desmoplasia is PDGF initiated. Oncogene 19, 4337–4345 (2000).
  Article CAS PubMed Google Scholar
• Armelin, H. A. Pituitary extracts and steroid hormones in the control of 3T3 cell growth. Proc. Natl Acad. Sci. USA 70, 2702–2706 (1973).
  Article CAS PubMed PubMed Central Google Scholar
• Folkman, J. et al. A heparin-binding angiogenic protein — basic fibroblast growth factor — is stored within basement membrane. Am. J. Pathol. 130, 393–400 (1988).
  CAS PubMed PubMed Central Google Scholar
• Strutz, F. et al. Basic fibroblast growth factor expression is increased in human renal fibrogenesis and may mediate autocrine fibroblast proliferation. Kidney Int. 57, 1521–1538. (2000).
  Article CAS PubMed Google Scholar
• Hay, E. D. An overview of epithelio–mesenchymal transformation. Acta Anat. 154, 8–20 (1995).
  Article CAS PubMed Google Scholar
• Thiery, J. P. Epithelial–mesenchymal transitions in tumor progression. Nature Rev. Cancer 2, 442–454 (2002). A good review on the role of EMT in cancer.
  Article CAS Google Scholar
• Kalluri, R. & Neilson, E. G. Epithelial–mesenchymal transition and its implications for fibrosis. J. Clin. Invest. 112, 1776–1784 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Fukino, K. et al. Combined total genome loss of heterozygosity scan of breast cancer stroma and epithelium reveals multiplicity of stromal targets. Cancer Res. 64, 7231–7236 (2004).
  Article CAS PubMed Google Scholar
• Tuhkanen, H. et al. Genetic alterations in the peritumoral stromal cells of malignant and borderline epithelial ovarian tumors as indicated by allelic imbalance on chromosome 3p. Int. J. Cancer 109, 247–252 (2004).
  Article CAS PubMed Google Scholar
• Ellsworth, D. L. et al. Genomic patterns of allelic imbalance in disease free tissue adjacent to primary breast carcinomas. Breast Cancer Res. Treat. 88, 131–139 (2004).
  Article CAS PubMed Google Scholar
• Kurose, K. et al. Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas. Nature Genet. 32, 355–357 (2002).
  Article CAS PubMed Google Scholar
• Petersen, O. W. et al. Epithelial to mesenchymal transition in human breast cancer can provide a nonmalignant stroma. Am. J. Pathol. 162, 391–402 (2003). An interesting study indicating that cancer cells can contribute to the accumulation of stromal fibroblasts by undergoing a complete EMT.
  Article CAS PubMed PubMed Central Google Scholar
• Zeisberg, M. & Kalluri, R. The role of epithelial-to-mesenchymal transition in renal fibrosis. J. Mol. Med. 82, 175–181 (2004).
  Article PubMed Google Scholar
• Zeisberg, M. et al. BMP-7 counteracts TGF-β1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nature Med. 9, 964–968 (2003). The first study to indicate that targeting EMT can reduce the numbers of tissue fibroblasts and reverse fibrosis.
  Article CAS PubMed Google Scholar
• Iwano, M. et al. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J. Clin. Invest. 110, 341–350. (2002). Provides evidence that FSP1 protein is a fibroblast-specific protein, and provides further evidence relating to the role of EMT in organ fibrosis.
  Article CAS PubMed PubMed Central Google Scholar
• Kopelovich, L. Genetic predisposition to cancer in man: in vitro studies. Int. Rev. Cytol. 77, 63–88 (1982).
  Article CAS PubMed Google Scholar
• Schor, S. L. et al. Occurrence of a fetal fibroblast phenotype in familial breast cancer. Int. J. Cancer 37, 831–836 (1986).
  Article CAS PubMed Google Scholar
• Kuperwasser, C. et al. Reconstruction of functionally normal and malignant human breast tissues in mice. Proc. Natl Acad. Sci. USA 101, 4966–4971 (2004). Demonstrates that fibroblasts aid mammary epithelia in forming functional breast tissue, and carcinogenesis.
  Article CAS PubMed PubMed Central Google Scholar
• Bhowmick, N. A. et al. TGF-β signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science 303, 848–851 (2004). Indicates that deletion of TGFβ type II receptor in FSP1-positive cells leads to the emergence of epithelial tumours.
  Article CAS PubMed Google Scholar
• Orimo, A. et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121, 335–348 (2005). Indicates a prominent role for fibroblasts in tumour angiogenesis facilitated by SDF1.
  Article CAS PubMed Google Scholar
• Olumi, A. F. et al. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res. 59, 5002–5011 (1999). A study that used co-culture methods to elucidate the role of CAFs in cancer progression.
  CAS PubMed Google Scholar
• Dimanche-Boitrel, M. T. et al. In vivo and in vitro invasiveness of a rat colon-cancer cell line maintaining E-cadherin expression: an enhancing role of tumor-associated myofibroblasts. Int. J. Cancer 56, 512–521 (1994).
  Article CAS PubMed Google Scholar
• Boire, A. et al. PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells. Cell 120, 303–313 (2005).
  Article CAS PubMed Google Scholar
• Stetler-Stevenson, W. G., Aznavoorian, S. & Liotta, L. A. Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu. Rev. Cell Biol. 9, 541–573 (1993).
  Article CAS PubMed Google Scholar
• Sternlicht, M. D. et al. The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis. Cell 98, 137–146 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Lochter, A. et al. Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-to-mesenchymal conversion and a premalignant phenotype in mammary epithelial cells. J. Cell Biol. 139, 1861–1872 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Olaso, E. et al. Tumor-dependent activation of rodent hepatic stellate cells during experimental melanoma metastasis. Hepatology 26, 634–642 (1997).
  Article CAS PubMed Google Scholar
• Olaso, E. et al. Proangiogenic role of tumor-activated hepatic stellate cells in experimental melanoma metastasis. Hepatology 37, 674–685 (2003).
  Article CAS PubMed Google Scholar
• Cornil, I. et al. Fibroblast cell interactions with human melanoma cells affect tumor cell growth as a function of tumor progression. Proc. Natl Acad. Sci. USA 88, 6028–6032 (1991).
  Article CAS PubMed PubMed Central Google Scholar
• Grum-Schwensen, B. et al. Suppression of tumor development and metastasis formation in mice lacking the S100A4 mts1 gene. Cancer Res. 65, 3772–3780 (2005).
  Article CAS PubMed Google Scholar
• Bhowmick, N. A., Neilson, E. G. & Moses, H. L. Stromal fibroblasts in cancer initiation and progression. Nature 432, 332–337 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Siegel, P. M. & Massague, J. Cytostatic and apoptotic actions of TGF-β in homeostasis and cancer. Nature Rev. Cancer 3, 807–821 (2003).
  Article CAS Google Scholar
• Bierie, B. & Moses, H. L. TGF-β and cancer. Cytokine Growth Factor Rev. 17, 29–40 (2006).
  Article CAS PubMed Google Scholar
• Derynck, R., Akhurst, R. J. & Balmain, A. TGF-β signaling in tumor suppression and cancer progression. Nature Genet. 29, 117–129 (2001).
  Article CAS PubMed Google Scholar
• Cheng, N. et al. Loss of TGF-β type II receptor in fibroblasts promotes mammary carcinoma growth and invasion through upregulation of TGF-α-, MSP- and HGF-mediated signaling networks. Oncogene 24, 5053–5068 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Silzle, T., Randolph, G. J., Kreutz, M. & Kunz-Schughart, L. A. The fibroblast: sentinel cell and local immune modulator in tumor tissue. Int. J. Cancer 108, 173–180 (2004).
  Article CAS PubMed Google Scholar
• Rettig, W. J. et al. Regulation and heteromeric structure of the fibroblast activation protein in normal and transformed cells of mesenchymal and neuroectodermal origin. Cancer Res. 53, 3327–3335 (1993).
  CAS PubMed Google Scholar
• Wang, X. M., Yu, D. M., McCaughan, G. W. & Gorrell, M. D. Fibroblast activation protein increases apoptosis, cell adhesion, and migration by the LX-2 human stellate cell line. Hepatology 42, 935–945 (2005).
  Article CAS PubMed Google Scholar
• Scott, A. M. et al. A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer. Clin. Cancer Res. 9, 1639–1647 (2003).
  CAS PubMed Google Scholar
• Zeisberg, M. et al. Bone morphogenic protein-7 inhibits progression of chronic renal fibrosis associated with two genetic mouse models. Am. J. Physiol. Renal Physiol. 285, F1060–F1067 (2003).
  Article CAS PubMed Google Scholar
• Zeisberg, M., Strutz, F. & Muller, G. A. Role of fibroblast activation in inducing interstitial fibrosis. J. Nephrol. 13 (Suppl. 3), S111–S120 (2000).
  PubMed Google Scholar
• Nakamura, T. et al. Hepatocyte growth factor prevents tissue fibrosis, remodeling, and dysfunction in cardiomyopathic hamster hearts. Am. J. Physiol. Heart Circ. Physiol. 288, H2131–H2139 (2005).
  Article CAS PubMed Google Scholar
• Kim, W. H., Matsumoto, K., Bessho, K. & Nakamura, T. Growth inhibition and apoptosis in liver myofibroblasts promoted by hepatocyte growth factor leads to resolution from liver cirrhosis. Am. J. Pathol. 166, 1017–1028 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Dai, C. et al. Intravenous administration of hepatocyte growth factor gene ameliorates diabetic nephropathy in mice. J. Am. Soc. Nephrol. 15, 2637–2647 (2004).
  Article CAS PubMed Google Scholar
• Isaka, Y. et al. Electroporation-mediated HGF gene transfection protected the kidney against graft injury. Gene Ther. 12, 815–820 (2005).
  Article CAS PubMed Google Scholar
• Yang, J., Dai, C. & Liu, Y. Hepatocyte growth factor gene therapy and angiotensin II blockade synergistically attenuate renal interstitial fibrosis in mice. J. Am. Soc. Nephrol. 13, 2464–2477 (2002).
  Article CAS PubMed Google Scholar
• McDonald, G. A. et al. Relaxin increases ubiquitin-dependent degradation of fibronectin in vitro and ameliorates renal fibrosis in vivo. Am. J. Physiol. Renal Physiol. 285, F59–F67 (2003).
  Article CAS PubMed Google Scholar
• Heeg, M. H. et al. The antifibrotic effects of relaxin in human renal fibroblasts are mediated in part by inhibition of the Smad2 pathway. Kidney Int. 68, 96–109 (2005).
  Article CAS PubMed Google Scholar
• Samuel, C. S. et al. Relaxin modulates cardiac fibroblast proliferation, differentiation, and collagen production and reverses cardiac fibrosis in vivo. Endocrinology 145, 4125–4133 (2004).
  Article CAS PubMed Google Scholar
• Seibold, J. R. et al. Recombinant human relaxin in the treatment of scleroderma. A randomized, double-blind, placebo-controlled trial. Ann. Intern. Med. 132, 871–879 (2000).
  Article CAS PubMed Google Scholar
• Binder, C. et al. Elevated concentrations of serum relaxin are associated with metastatic disease in breast cancer patients. Breast Cancer Res. Treat. 87, 157–166 (2004).
  Article CAS PubMed Google Scholar
• Binder, C., Hagemann, T., Husen, B., Schulz, M. & Einspanier, A. Relaxin enhances in-vitro invasiveness of breast cancer cell lines by up-regulation of matrix metalloproteases. Mol. Hum. Reprod. 8, 789–796 (2002).
  Article CAS PubMed Google Scholar
• Lazarides, E. & Balzer, D. R. Jr. Specificity of desmin to avian and mammalian muscle cells. Cell 14, 429–438 (1978).
  Article CAS PubMed Google Scholar
• Franke, W. W., Schmid, E., Osborn, M. & Weber, K. Different intermediate-sized filaments distinguished by immunofluorescence microscopy. Proc. Natl Acad. Sci. USA 75, 5034–5038 (1978).
  Article CAS PubMed PubMed Central Google Scholar
• Franke, W. W., Schmid, E., Osborn, M. & Weber, K. Intermediate-sized filaments of human endothelial cells. J. Cell Biol. 81, 570–580 (1979).
  Article CAS PubMed Google Scholar
• Mork, C., van Deurs, B. & Petersen, O. W. Regulation of vimentin expression in cultured human mammary epithelial cells. Differentiation 43, 146–156 (1990).
  Article CAS PubMed Google Scholar
• Schmid, E. et al. Distribution of vimentin and desmin filaments in smooth muscle tissue of mammalian and avian aorta. Exp. Cell Res. 137, 329–340 (1982).
  Article CAS PubMed Google Scholar
• Strutz, F. et al. Identification and characterization of a fibroblast marker: FSP1. J. Cell Biol. 130, 393–405 (1995).
  Article CAS PubMed Google Scholar
• Vogel, W., Gish, G. D., Alves, F. & Pawson, T. The discoidin domain receptor tyrosine kinases are activated by collagen. Mol. Cell 1, 13–23 (1997).
  Article CAS PubMed Google Scholar
• Goldsmith, E. C. et al. Organization of fibroblasts in the heart. Dev. Dyn. 230, 787–794 (2004).
  Article CAS PubMed Google Scholar
• Ramirez-Montagut, T. et al. FAPα, a surface peptidase expressed during wound healing, is a tumor suppressor. Oncogene 23, 5435–5446 (2004).
  Article CAS PubMed Google Scholar
• Gardner, H., Kreidberg, J., Koteliansky, V. & Jaenisch, R. Deletion of integrin α1 by homologous recombination permits normal murine development but gives rise to a specific deficit in cell adhesion. Dev. Biol. 175, 301–313 (1996).
  Article CAS PubMed Google Scholar
• Sudhakar, A. et al. Human α1 type IV collagen NC1 domain exhibits distinct antiangiogenic activity mediated by α1β1 integrin. J. Clin. Invest. 115, 2801–2810 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Mussini, E., Hutton, J. J. Jr & Udenfriend, S. Collagen proline hydroxylase in wound healing, granuloma formation, scurvy, and growth. Science 157, 927–929 (1967).
  Article CAS PubMed Google Scholar
• Langness, U. & Udenfriend, S. Collagen biosynthesis in nonfibroblastic cell lines. Proc. Natl Acad. Sci. USA 71, 50–51 (1974).
  Article CAS PubMed PubMed Central Google Scholar
• Florin, L. et al. Cre recombinase-mediated gene targeting of mesenchymal cells. Genesis 38, 139–144 (2004).
  Article CAS PubMed Google Scholar
• Hogan, B. L. & Yingling, J. M. Epithelial–mesenchymal interactions and branching morphogenesis of the lung. Curr. Opin. Genet. Dev. 8, 481–486 (1998).
  Article CAS PubMed Google Scholar
• Clayton, A. et al. Cellular activation through the ligation of intercellular adhesion molecule-1. J. Cell Sci. 111, 443–453 (1998).
  Article CAS PubMed Google Scholar
• Strieter, R. M. et al. Monocyte chemotactic protein gene expression by cytokine-treated human fibroblasts and endothelial cells. Biochem. Biophys. Res. Commun. 162, 694–700 (1989).
  Article CAS PubMed Google Scholar
• Rollins, B. J., Stier, P., Ernst, T. & Wong, G. G. The human homolog of the JE gene encodes a monocyte secretory protein. Mol. Cell. Biol. 9, 4687–4695 (1989).
  CAS PubMed PubMed Central Google Scholar
• Duda, D. G. et al. Differential transplantability of tumor-associated stromal cells. Cancer Res. 64, 5920–5924 (2004).
  Article CAS PubMed Google Scholar
• Grupp, C. et al. A novel model to study renal myofibroblast formation in vitro. Kidney Int. 59, 543–553 (2001).
  Article CAS PubMed Google Scholar